- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
NUS
NYSE
Week ended 24 Jul 2026
Weekly Investor Report
Nu Skin Enterprises Inc · Consumer Defensive · Household & Personal Products
Latest close
5.08 USD
-3.1%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -30.9% below the Trend Line and sits at 2.0% of its 52-week range. The latest completed week returned -3.1%, after a -3.8% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is inexpensive relative to peers. Options positioning is volatility with 52/100 conviction, while the latest news-sentiment score is 47/100. Near-term considerations: volume confirmation is below normal; earnings are due in 7d.
Setup score
21
out of 100
Latest Close
5.08 USD
24 Jul 2026
1W Return
-3.1%
latest completed week
4W Return
-3.8%
short-term follow-through
12W Return
-28.6%
quarterly tape
Trend Breadth
46.2%
24 of 52 weeks active
Volume Ratio
0.7x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-3.1%
Latest completed week; four-week move -3.8%.
Indicator stack
25/29
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Options pressure
Volatility
52/100 conviction; expected move 15.3%.
News sentiment
47/100
44 relevant articles in the latest sentiment read.
Event risk
7d
Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -30.9% below the Trend Line and sits at 2.0% of its 52-week range. The latest completed week returned -3.1%, after a -3.8% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0112-week average 0.02
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.01Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -3.8% over four weeks, -28.6% over 12 weeks, and -40.3% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year24
Trend breadth46.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-1.14Latest activity-pressure read.
Pressure change-9.5%Four-week change in activity pressure.
Leadership-46.20Latest relative-leadership reading.
RS change-1.4%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is inexpensive relative to peers.
Factor week 26 Jul 2026
Financial statements through 31 Dec 2025
Field coverage 97%
Model confidence 93%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength71/100Blend of value, momentum, and quality. Underlying universe rank 30; rank 1 is best.
Value99/100Relative valuation strength. Underlying universe rank 2; rank 1 is best.
Quality33/100Profitability and accounting quality. Underlying universe rank 68; rank 1 is best.
Momentum8/100Medium-term price momentum. Underlying universe rank 93; rank 1 is best.
Growth6/100Revenue and earnings growth. Underlying universe rank 95; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework87/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 4.5x Price divided by trailing earnings.
- Price / sales
- 0.2x Market value relative to trailing revenue.
- EV / EBITDA
- 2.5x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 33.9% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 69.3% Gross profit retained from each unit of revenue.
- Operating margin
- 5.5% Operating profit retained from revenue.
- Free-cash-flow margin
- 7.7% Free cash flow generated from revenue.
- Return on invested capital
- 7.7% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- -14.2% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -27.2% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 4.7% Cash dividends relative to market value.
- Buyback yield
- 8.1% Net share repurchases relative to market value.
- Shareholder yield
- 12.8% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.6x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Options positioningVolatility
NUS shows volatility options pressure with a 52/100 conviction score, put-call volume ratio of 0.00, expected move of 15.3%, and Sharemaestro trend signal inactive.
Conviction52/100
Expected move15.3%
Put/call volume0.00
Insider activity8 / 3
8 acquisitions and 3 disposals in the latest 180-day insider tape.
Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.News sentiment47/100
Weighted news tone is neutral across 44 relevant articles.
3 positive · 30 neutral · 11 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings7dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move15.3%Nearest-chain priced movement where available.
52-week drawdown-64.4%Distance below the 52-week high.
13-week volatility5.2%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
27 Mar
24 Apr
22 May
19 Jun
24 Jul
Weeks higher10 of 2616 weeks finished lower.
Best week+5.2%Week of 26 Jun.
Worst week-22.7%Week of 13 Feb.
Latest week-3.1%Week of 24 Jul.
Shape of recent returns
Strong gains4
Modest gains6
Flat weeks0
Modest losses6
Sharp losses10
Recent vol5.2%13-week weekly-return volatility.
Base vol7.5%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew4.8% / -5.8%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Consumer Defensive
4-week rank- / 100
Group average-0.3%
Trend breadth49.0%
Trend49.0%active weekly trend signals
MD58.0%positive activity pressure
RS33.0%positive relative leadership
Four-week leaders
IndustryUS Household & Personal Products
4-week rank26 / 28
Group average4.4%
Trend breadth39.3%
Trend39.3%active weekly trend signals
MD85.7%positive activity pressure
RS32.1%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape22/100
Trend, activity pressure, participation, and risk combine to a 22/100 tape read.
Indicator analysis9/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.01; No reversal markers Factors53/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Tiny Titans rank 57; Buyback Yield rank 7; Small Cap Core rank 1 SVQF87/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 130.5 of 1013 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Options35/100NUS shows volatility options pressure with a 52/100 conviction score, put-call volume ratio of 0.00, expected move of 15.3%, and Sharemaestro trend signal inactive.
Volatility · Volatility expansion watch · Expected move 15.3% Sentiment47/100Weighted news tone is neutral across 44 relevant articles.
Enterprise value to EBITDA forward of Nu Skin Enterprises, Inc. Class A – BX:NUS Insiders8 / 38 acquisitions and 3 disposals in the latest 180-day insider tape.
Earnings7dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 24 Jul 2026 | 5.08 USD | -3.1% | 7.35 USD | 10.39 USD | -1.14 | -46.20 | 2.4M | Off |
| 17 Jul 2026 | 5.24 USD | 0.2% | 7.50 USD | 10.53 USD | -0.99 | -45.38 | 3.3M | Off |
| 10 Jul 2026 | 5.23 USD | 4.4% | 7.67 USD | 10.66 USD | -0.99 | -46.80 | 3.1M | Off |
| 3 Jul 2026 | 5.01 USD | -5.1% | 7.84 USD | 10.80 USD | -0.98 | -48.92 | 3.6M | Off |
| 26 Jun 2026 | 5.28 USD | 5.2% | 8.00 USD | 10.94 USD | -1.04 | -45.58 | 4.5M | Off |
| 19 Jun 2026 | 5.02 USD | -8.2% | 8.15 USD | 11.10 USD | -1.26 | -49.90 | 5.0M | Off |
| 12 Jun 2026 | 5.47 USD | 1.9% | 8.31 USD | 11.25 USD | -1.30 | -45.37 | 2.9M | Off |
| 5 Jun 2026 | 5.37 USD | -7.3% | 8.44 USD | 11.41 USD | -1.33 | -46.45 | 3.8M | Off |
| 29 May 2026 | 5.79 USD | -1.3% | 8.56 USD | 11.58 USD | -1.21 | -44.16 | 2.6M | Off |
| 22 May 2026 | 5.87 USD | -3.1% | 8.71 USD | 11.74 USD | -1.14 | -43.12 | 3.6M | Off |
| 15 May 2026 | 6.06 USD | -14.5% | 8.87 USD | 11.90 USD | -1.19 | -41.14 | 3.9M | Off |
| 8 May 2026 | 7.09 USD | -0.4% | 9.02 USD | 12.07 USD | -1.17 | -31.39 | 3.2M | Off |
| 1 May 2026 | 7.12 USD | -4.6% | 9.12 USD | 12.23 USD | -1.28 | -29.70 | 2.1M | Off |
| 24 Apr 2026 | 7.46 USD | -4.6% | 9.25 USD | 12.41 USD | -1.32 | -25.66 | 2.0M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.